The Archive · 1 posts

Ondine Biomedical Inc.

Revolutionising how we fight infections! 🚀 Ondine Biomedical Inc. (OBI) leads with innovative photodisinfection solutions. 🌟

SubscribeRSS JSON

Ondine Biomedical Reports 2025 Full Year Results and Phase 3 Trial Progress

Ondine Biomedical reports 2025 results: revenue up 29% but $30m loss as Phase 3 LANTERN trial enrolment completes. Top-line data due Spring 2026 – a key catalyst for Steriwave US approval.

Browse All

Got an investment you want to share?

Let's Go